Copeptin, a surrogate marker for arginine vasopressin secretion, is associated with higher glucose and insulin concentrations but not higher blood pressure in obese men
Abstract
Aim: To explore the putative associations of plasma copeptin, the C‐terminal portion of provasopressin and a surrogate marker for arginine vasopressin secretion, with obesity‐related health problems, such as hyperlipidaemia, hyperinsulinaemia, hyperglycaemia, high blood pressure and an android fat distribution. Methods: In 103 obese men (mean age ± standard deviation: 49.4 ± 10.2 years) and 27 normal weight control men (mean age: 51.5 ± 8.4 years), taking no medication, we measured 24‐h ambulatory blood pressure, fasting blood concentrations of copeptin, lipids, glucose and insulin, and determined body composition by dual energy X‐ray absorptiometry scanning. Results: The obese men had higher [median (interquartile range)] plasma copeptin concentrations [6.6 (4.6–9.5) vs. 4.9 (3.5–6.8) pmol/l, P = 0.040] compared with the normal weight men. In the obese men, plasma copeptin was not related to 24‐h systolic blood pressure (r = 0.11, P = 0.29), 24‐h diastolic blood pressure (r = 0.11, P = 0.28), BMI (r = 0.09, P = 0.37), total body fatness percentage (r = 0.10, P = 0.33), android fat mass percentage (r = 0.04, P = 0.66) or serum triglyceride concentrations (r = 0.04; P = 0.68). In contrast, plasma copeptin was associated with higher serum insulin concentrations (r = 0.26, P = 0.0085) and insulin resistance as assessed by the homeostasis assessment model (r = 0.28, P = 0.0051). Conclusions: Plasma copeptin, a surrogate marker for arginine vasopressin secretion, is higher in obese men compared with normal weight men, and is associated with abnormalities in glucose and insulin metabolism, but not with higher blood pressure or an android fat distribution in obese men.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Increased levels of copeptin have been demonstrated in obese individuals.
“Increased levels of copeptin have been demonstrated in obese individuals (12).”
From Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS (2018) · cites this paper as [12]
Levels of copeptin are increased in individuals with obesity and insulin resistance.
“As levels of copeptin are increased in individuals with obesity and IR (12, 43)”
From Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS (2018) · cites this paper as [12]
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655 · see citing works
Assay for the Measurement of Copeptin, a Stable Peptide Derived from the Precursor of Vasopressin
Morgenthaler, N. G., Struck, J., Alonso, C., & Bergmann, A. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.060038 · Cited by 1,166 · see citing works
Physiology of Vasopressin Relevant to Management of Septic Shock
Holmes, C. L., Patel, B. M., Russell, J. A., & Walley, K. R. (2001) · Chest · doi:10.1378/chest.120.3.989 · Cited by 620 · see citing works
Role of stress in the pathogenesis of the metabolic syndrome
Rosmond, R. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.05.007 · Cited by 516 · see citing works
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299 · see citing works
Enhörning, S., Bankir, L., Bouby, N., Struck, J., Hedblad, B., Persson, M., Morgenthaler, N. G., Nilsson, P. M., & Melander, O. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.88 · Cited by 193 · see citing works
Bench-to-bedside review: Vasopressin in the management of septic shock
Russell, J. A. (2009) · Critical Care · doi:10.1186/cc8224 · Cited by 177 · see citing works
Plasma Copeptin, A Unifying Factor behind the Metabolic Syndrome
Enhörning, S., Struck, J., Wirfält, E., Hedblad, B., Morgenthaler, N. G., & Melander, O. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2981 · Cited by 177 · see citing works
Saleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2278 · Cited by 161 · see citing works
Alehagen, U. (2011) · JAMA · doi:10.1001/jama.2011.666 · Cited by 134 · see citing works
Bombelli, M., Facchetti, R., Sega, R., Carugo, S., Fodri, D., Brambilla, G., Giannattasio, C., Grassi, G., & Mancia, G. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.175125 · Cited by 126 · see citing works
Asferg, C. L., Nielsen, S. J., Andersen, U. B., Linneberg, A., Møller, D. V., Hedley, P. L., Christiansen, M., Goetze, J. P., Esler, M., & Jeppesen, J. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00791 · Cited by 58 · see citing works
Self-citationHome Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring
Verdecchia, P., Angeli, F., Mazzotta, G., Gentile, G., & Reboldi, G. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.122861 · Cited by 57 · see citing works
Hansen, T. W., Kikuya, M., Thijs, L., Li, Y., Boggia, J. G., Björklund‐Bodegârd, K., Torp-Pedersen, C. T., Jeppesen, J., Ibsen, H., & Staessen, J. A. (2008) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07681.x · Cited by 36 · see citing works
Self-citationEvaluation of a Sensitive Copeptin Assay for Clinical Measurement
Terzic, D. (2012) · The Open Clinical Chemistry Journal · doi:10.2174/1874241601205010021 · Cited by 20 · see citing works
Diabetes and Hypertension and Atherosclerotic Cardiovascular Disease
Torp-Pedersen, C. T., & Jeppesen, J. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.168583 · Cited by 12 · see citing works
Self-citationCopeptin concentrations are not elevated in gestational diabetes mellitus
Öncül, M., Tüten, A., Kücür, M., İmamoğlu, M., Ekmekçi, Ö. B., Açıkgöz, A. S., & Madazlı, R. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-2887-8 · Cited by 11 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Frøssing, S., Nylander, M., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Endocrine Connections · doi:10.1530/ec-17-0327 · Cited by 38 · see citing works
- Authors
- Asferg, C. L., Andersen, U. B., Linneberg, A., Goetze, J. P., & Jeppesen, J. L.
- Affiliations
- Department of Diagnostics
- University of Copenhagen (DK)
- Corresponding author
- Asferg, C. L.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2014-03-06
- Volume
- 31
- Issue
- 6
- Pages
- 728-732
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2064487208
- Semantic Scholar
- 1aa011dec307db446ea9dd2ff6ae286560325a97
- Cited by
- 26
- References
- 18
- Citations by year
- 2026: 1 · 2024: 1 · 2022: 1 · 2021: 2 · 2020: 6 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 5 · 2015: 2
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Hjerteforeningen
- Novo Nordisk Fonden
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- copeptin, obesity, hyperinsulinemia, hyperglycemia, insulin resistance, blood pressure, android fat distribution, hyperlipidemia
- MeSH terms
- Adipose Tissue, Arginine Vasopressin, Blood Glucose, Diabetes Mellitus, Type 2, Glycopeptides, Humans, Hypertension, Insulin, Male, Middle Aged, Obesity, Biomarkers, Body Mass Index, Glucose Intolerance, Body Fat Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
